Hot Life Science Investor Mandate 3: European VC Looking Throughout US and Europe for Early Stage Investments

24 Apr

A European Venture Capital firm is looking to invest exclusively invests in early stage life science companies. The firm makes seed and early stage investments typically in the Series A round and can allocate €1-10M initially and an additional €10-15M in a follow-on investment per company. The firm typically co-invests with other institutional investors for larger investments. The firm is actively seeking opportunities throughout United States and Europe.

The firm is currently looking for biotech therapeutics, medical devices, and industrial biotech. For therapeutics, the firm invests in small molecule and biologics as well as cell and gene therapy. The firm is open to all indications as well as orphan indications. The firm will consider products as early as 24-month from IND through to Phase II. For medical devices, the firm seeks paradigm-shifting technologies that can reach a human proof-of-concept stage in a relatively short period of time.

The firm prefers to lead or co-lead an investment and generally require a board seat in its portfolio companies.

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: